With the treatment paradigm for stroke continuing to evolve, meaningful innovation relies on advancing both stroke products and services. Through Stryker’s Stroke Knowledge Initiatives for Learning and Leadership (SKILL), and StrokEnomics—the brand name associated with health economics at Stryker’s neurovascular division—the company explores targeted opportunities and delivers proven solutions that help drive both economic value, and patient outcomes.
In this educational supplement, Stryker outline their full portfolio, detailing the evolution of the company’s next generation flow diverter, Surpass Evolve, for the treatment of haemorrhagic stroke, while also exhibiting their full range of ischaemic stroke care solutions.
